With significant upside potential, Sanofi (NASDAQ:SNY) secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts. On September 29, Berenberg reaffirmed its Buy ...
Novo Nordisk has resubmitted its BLA for Awiqli, a once-weekly insulin, backed by ONWARDS trial data. FDA approval could change type 2 diabetes care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback